THOMAS.MATTHEWS LIMITED

Company number 04425741 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: THOMAS.MATTHEWS LIMITED

1. Financial Health Score: C+ (Stable but Inactive)

Explanation: The patient is in a state of suspended animation. There are absolutely no symptoms of financial distress—no debt, no liabilities, and no losses. However, there is also no pulse. A business exists to generate revenue and profit, and this company has had a flatlined heartbeat since its birth. It receives a C+ rather than a failing grade because it is financially sound and faces no immediate threat of insolvency, but it is not fulfilling its biological purpose as a trading entity.

2. Key Vital Signs

  • Pulse (Trading Activity): Flatline. The accounts explicitly state that the company has never traded. There is no revenue, no cost of sales, and no operational pulse.
  • Blood Pressure (Net Assets & Equity): Stable but minimal. Net assets and shareholders' funds have remained at exactly £100 for at least the last decade. This is the bare minimum of financial blood in the system—just enough to keep the legal entity technically alive based on its issued share capital.
  • White Blood Cell Count (Liabilities): Clear. There are zero current or long-term liabilities. The company has no financial infections or toxic debts threatening its existence.
  • Hydration (Cash Reserves): £100. The cash at bank perfectly matches the share capital. This is the financial equivalent of an IV drip keeping the patient hydrated—just enough to maintain registration, but not enough to sustain any real activity.

3. Diagnosis: Clinical Dormancy

The financial data reveals a clear diagnosis: Clinical Dormancy. THOMAS.MATTHEWS LIMITED is a corporate shell. While registered to perform "specialised design activities" (SIC 74100), it has never actually practiced this trade.

The condition is not the result of a once-healthy business falling into a coma; rather, the patient was born dormant. The £100 held in cash is merely the initial capital injected by the shareholders to open the legal "airways" at incorporation, and it has sat untouched ever since.

The presence of a corporate Person with Significant Control (Useful Simple Limited, owning more than 75% of shares) suggests that this entity is likely a subsidiary kept on life support within a wider corporate group structure—perhaps held in reserve for a future project, or simply maintained because there is no urgent reason to strike it off the register.

4. Recommendations: Prescribing Action

To improve the financial wellness and utility of this entity, stakeholders should consider the following treatments:

  • Reanimate with Purpose: If the parent company (Useful Simple Limited) or the directors intend to use this vehicle for specialised design activities, they must inject working capital and commence trading. A business cannot survive indefinitely on a £100 IV drip; it needs the nourishment of revenue and active operations.
  • Graceful Euthanasia (Striking Off): If there are no future plans to operate this business, the healthiest course of action is to voluntarily dissolve the company. While dormant companies do not incur trading costs, they still require annual administrative maintenance (Confirmation Statements, dormant accounts filing). Removing the patient from the register entirely saves administrative energy and focus.
  • Maintain the Life Support (Compliance): If the decision is made to keep the entity dormant as a strategic reserve, it is vital that the life support machines keep running. This means ensuring Confirmation Statements and dormant accounts are filed on time with Companies House to prevent statutory penalties or forced striking off.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 4 September 2026